Precision Sells Off Autoimmune Rights For Allogeneic CAR-T To TG Therapeutics

 
• By Alaric DeArment
  
TG and Precision signed a deal for Precision's off-the-shelf CAR-T, both companies having recently made strategic pivots. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business